Mr. Liam Woods:

In our environment, that is, in effect, the rare diseases office and the service provided through it. Could that happen at a wider European level? That is about the connectivity between clinicians. From our point of view, the work the office does here can support patients in identifying expertise elsewhere so some of that is in place already. I do not really have anything further to say on that.